The ISPE Tech Show is an opportunity for industry professionals to share practical lessons, project experiences, and approaches that have helped their organizations move forward with greater confidence.
We invite engineers, facility leaders, quality professionals, operations teams, consultants, contractors, and technology providers to submit abstracts for educational presentations that offer meaningful takeaways for pharmaceutical industry professionals at this year’s Tech Show.
What We Are Looking For
Attendees want more than theory and hypotheticals. They want to hear real-world examples of what worked, what didn't, and what others would do differently if given the chance.
Strong presentations and panel topics should address:
- A real challenge or opportunity
- The approach that you or your team took
- Results achieved and lessons learned
- Recommendations other organizations can apply
Preference will be given to presentations that align with this year’s suggested topics (below) taken from our survey results and also ones that focus on practical applications, case studies, and measurable outcomes.
Suggested Topics
- Workforce & Future Skills: Focused on workforce development, hiring, training, reskilling, and preparing teams for the evolving needs of life sciences manufacturing.
- Tech Transfer, Facility Setup & Operational Readiness: Addressing technology transfer, process scale-up, new facility setup, manufacturing startup, and preparing sites, systems, and teams for successful operations.
- Capital Projects & Sustainable Operations: Focused on capital project planning and execution, supply chains & onshoring, operational performance, resource efficiency, waste reduction, and sustainable manufacturing.
- AI, Digital & Smart Manufacturing: Exploring how AI, automation, data, digital technologies, and connected systems are being used to improve manufacturing, quality, engineering, and operations.
- Life Sciences Innovation, Investment & Growth: Focused on emerging therapeutic areas, startups, venture capital and investment, M&A and partnerships shaping where the life sciences industry is headed.